CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Celtarys develops a patented chemical conjugation technology that enhances the creation of fluorescent tools for drug discovery. This innovative approach aims to streamline the identification of new drugs for personalized medicine, improving efficiency and reducing costs in the early phases of development.
Drug discovery faces two key challenges: on one hand, the sector has been losing competitiveness due to an increase in development costs and a reduction in sales; and on the other hand, the new therapeutical targets that appear every year, in part thanks to the potential of personalized medicine, demand urgently new research tools to efficiently identify new drugs acting on them.
Celtarys proprietary technology provides a solution to both challenges: it is a new and disruptive patented chemical…
CELTARYS RESEARCH SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
